Manufacturer CAS 66108-95-0 Iohexol Iodide Iohexol

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: QS-Iohexol
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Iohexol
• Name: Iohexol Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• Mf: C19h26I3n3o9
• MW: 821.142
• CAS: 66108-95-0
• Density: 2.2
• Melting Point: 254-2560c
• Boiling Point: 760 Mmhg
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Iohexol
• Origin: Xian
• Production Capacity: 500kg/Month

Product Description

Manufacturer CAS 66108-95-0 Iohexol Iodide Iohexol

Product Description

Product Details

Product Name	Iohexol
Appearance	White Powder
Assay	99%
MW	821.142
MF	C19H26I3N3O9

Iohexol is a non-ionic contrast agent primarily used in medical imaging to enhance the contrast effect of X-rays or other imaging techniques. It helps doctors to observe blood vessels, urinary tract, spinal cord, joints, and other body structures more clearly by increasing the density differences in specific areas of the body, thereby assisting in the diagnosis of diseases.

Application&Function

Iohexol (CAS number 66108-95-0) is a non-ionic contrast agent mainly used for angiography, urinary system, spinal cord and femoral joint, and lymphatic system imaging.
The drug mechanism of action of Iohexol is mainly reflected in the following aspects:
Intravascular application: Suitable for urography and cardiovascular angiography in adults and children, as well as cerebral angiography, peripheral and various arterial angiography, venous angiography, digital subtraction and CT enhanced scanning in adults.
Subarachnoid application: suitable for spinal cord imaging in adults and children, as well as for subarachnoid space, injection followed by cerebral CT scan examination.
Intraluminal application: Suitable for various body cavity examinations, including oral administration such as arthrography, endoscopic retrograde cholangiopancreatography (ERCP), hernia sac angiography, urography, hysterosalpingography, sialosalpingography, and various gastrointestinal examinations using oral water-soluble contrast agents.

Specification